ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0502

The Effect of Osteoporosis on Developing Vertebral Compression Fracture After Single-level Posterior Lumbar Fusion Surgery: A Large Healthcare Claims Database Study

Vartika Kesarwani1, Sean Esmende2, Regina Kostyun2, Matthew Solomito2, Heeren Makanji2, John Magaldi2 and Mandeep Kumar2, 1University of Connecticut, Farmington, CT, 2Bone and Joint Institute, Hartford Hospital, Hartford, CT

Meeting: ACR Convergence 2022

Keywords: Fracture, Orthopedics, osteoporosis, Outcome measures, surgery

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Abstracts: Orthopedics, Low Back Pain, and Rehabilitation

Session Type: Abstract Session

Session Time: 3:00PM-4:00PM

Background/Purpose: Vertebral compression fracture (VCF) is a significant osteoporosis-related complication (ORC) associated with instrumented spinal fusion. Various studies have assessed the development of VCF in patients undergoing three or greater level spinal fusion. There is a gap in the assessment of VCF following single-level fusion, which may predispose patients to greater stress due to the lack of fixation points. This study aimed to examine the occurrence of VCF among patients with osteoporosis undergoing instrumented single-level posterior lumbar fusion (SLPF) surgery. We hypothesized that surgical patients with osteoporosis would have a greater incidence of compression fractures within the year following surgery than surgical patients without osteoporosis and the year following diagnosis of osteoporosis in the non-surgical group.

Methods: This was a retrospective cohort study using a commercially available medical claims database, PearlDiver. Patient records from 2011 to 2019 were queried and filtered (Figure 1) to identify patients who had an SLPF procedure following a diagnosis of osteoporosis (OP Fusion Group), patients with an SLPF procedure without a preexisting diagnosis of osteoporosis (No OP Fusion Group), and patients with osteoporosis who did not have an SLPF within a year of diagnosis (OP Group). The primary outcomes were the development of a VCF within the year following SLPF for the surgical group or within the year of osteoporosis diagnosis for the control group. Statistical analyses were performed using R software. Differences in the rate of VCF were assessed using chi-square tests. Univariate and multivariate logistic regression analyses were used to understand the association between osteoporosis and SLPF and covariates to VCF.

Results: The query identified 694 patients in the OP Fusion, 25,935 in the No OP Fusion, and 18,455 in the OP Group. Majority were females (OP Fusion = 90%, No OP Fusion = 58.4%, and OP Group = 85%). There were a higher number of patients > 60 years in the OP Fusion and OP Group (78% and 73%) compared to the No OP Fusion Group (53%). A greater number of VCF were diagnosed among patients in the OP Fusion compared to the No OP Fusion Group within the year following SLPF (χ2=10.8 p=0.001) (Table 1). There was no difference in VCF rates between OP Fusion and the OP Group (p=0.218). Univariate logistic analyses identified that female gender, age 70-84 years, Charlson Comorbidity Index (CCI), and osteoporosis pharmacotherapy were associated with developing a VFC after SLPF. After including these variables in the multivariate model, osteoporosis was no longer a risk factor for developing VCF after SLPF (Table 2).

Conclusion: In this large multi-year cohort, the incidence rate of VCF was less than 2%. A pre-operative diagnosis of osteoporosis alone may not be an independent risk factor for developing VCF following SLPF. Other clinical factors such as female gender, 70 years of age or older, higher CCI scores, and osteoporosis treatment should be considered when determining the risk for VCF following surgery.

Supporting image 1

Figure 1: Flow chart for inclusion and exclusion criteria of the patient query.

Supporting image 2

Table 1: Incidence of VCF among patients with osteoporosis underdoing SLPF.

Supporting image 3

Table 2: Unadjusted and adjusted multivariate analysis for developing a VCF within the year after surgery.


Disclosures: V. Kesarwani, None; S. Esmende, None; R. Kostyun, None; M. Solomito, None; H. Makanji, None; J. Magaldi, None; M. Kumar, None.

To cite this abstract in AMA style:

Kesarwani V, Esmende S, Kostyun R, Solomito M, Makanji H, Magaldi J, Kumar M. The Effect of Osteoporosis on Developing Vertebral Compression Fracture After Single-level Posterior Lumbar Fusion Surgery: A Large Healthcare Claims Database Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-effect-of-osteoporosis-on-developing-vertebral-compression-fracture-after-single-level-posterior-lumbar-fusion-surgery-a-large-healthcare-claims-database-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-osteoporosis-on-developing-vertebral-compression-fracture-after-single-level-posterior-lumbar-fusion-surgery-a-large-healthcare-claims-database-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology